Eyeworld

3 EW NEWS & OPINION by Lauren Lipuma EyeWorld Staff Writer Combined Ophthalmic Symposium promises exciting program July 2015 Saturday's opening session. The first part of the session, "Phaco Funda- mentals: Common to Complex," Program will focus on fundamentals as well as complicated and challenging cases A SCRS•ASOA will host the Combined Ophthal- mic Symposium (COS) next month, offering exceptional educational programming for the entire ophthal- mic practice in one weekend. The meeting will take place at the brand new JW Marriott hotel in Austin, Texas, from August 21–23, with programs for residents and fellows, ophthalmologists, practice manag- ers, integrated practice optometrists, and nurses and technicians. The COS meeting has tradi- tionally been held in San Antonio, Texas. This is the first year the meet- ing will be held in Austin and the second year that it will be hosted by ASCRS•ASOA. Three physicians from Baylor College of Medicine, Houston, will chair the physicians program: Douglas D. Koch, MD, professor and Allen, Mosbacher, and Law chair in ophthalmology, Alkek Eye Center; Sumitra S. Khandelwal, MD, assistant professor, Cullen Eye Institute; and Mitchell P. Weikert, MD, associate professor, Alkek Eye Center. "This program has been long-standing in the community, although it has undergone several name changes," Dr. Khandelwal said in an interview with EyeWorld. "We are very excited to work with ASCRS, but also to keep the flavor of this very educational and popular meeting for our esteemed anterior segment ophthalmologists. "We expect physicians to leave the meeting with a collection of pearls they can use the very next week in their clinics," she said. Attendees will walk away with an excellent review of basics in ante- rior segment surgery as well as tools for managing complicated and chal- lenging clinical and surgical cases. "This year we will have several panel discussions from top surgeons across the country to highlight challenges in clinical and surgical practice for the anterior segment," Dr. Khandelwal said. "We look for- ward to these expert discussions and lively debates that will engage the audience as well." Here's a day-by-day breakdown of the meeting's programming. Friday The residents and fellows program will take place on Friday, August 21. Designed with the early-career oph- thalmologist in mind, this program includes skills transfer sessions and roundtable discussions on managing complex and challenging cases. Saturday The physicians program will take place on Saturday, August 22 and Sunday, August 23. Phaco fundamentals will be the focus of ACRYSOF® IQ INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION CAUTION: FEDERAL (USA) LAW RESTRICTS THIS DEVICE TO THE SALE BY OR ON THE ORDER OF A PHYSICIAN. INDICATIONS: THE ACRYSOF® IQ POSTERIOR CHAMBER INTRAOCULAR LENS IS INTENDED FOR THE REPLACEMENT OF THE HUMAN LENS TO ACHIEVE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS FOLLOWING CATARACT SURGERY. THIS LENS IS INTENDED FOR PLACEMENT IN THE CAPSULAR BAG. WARNINGS/PRECAUTIONS: CAREFUL PREOPERATIVE EVALUATION AND SOUND CLINICAL JUDGMENT SHOULD BE USED BY THE SURGEON TO DECIDE THE RISK/BENEFIT RATIO BEFORE IMPLANTING A LENS IN A PATIENT WITH ANY OF THE CONDITIONS DESCRIBED IN THE DIRECTIONS FOR USE LABELING. CAUTION SHOULD BE USED PRIOR TO LENS ENCAPSULATION TO AVOID LENS DECENTRATIONS OR DISLOCATIONS. STUDIES HAVE SHOWN THAT COLOR VISION DISCRIMINATION IS NOT ADVERSELY AFFECTED IN INDIVIDUALS WITH THE ACRYSOF® NATURAL IOL AND NORMAL COLOR VISION. THE EFFECT ON VISION OF THE ACRYSOF® NATURAL IOL IN SUBJECTS WITH HEREDITARY COLOR VISION DEFECTS AND ACQUIRED COLOR VISION DEFECTS SECONDARY TO OCULAR DISEASE (E.G., GLAUCOMA, DIABETIC RETINOPATHY, CHRONIC UVEITIS, AND OTHER RETINAL OR OPTIC NERVE DISEASES) HAS NOT BEEN STUDIED. DO NOT RESTERILIZE; DO NOT STORE OVER 45° C; USE ONLY STERILE IRRIGATING SOLUTIONS SUCH AS BSS® OR BSS PLUS® STERILE INTRAOCULAR IRRIGATING SOLUTIONS. ATTENTION: REFERENCE THE DIRECTIONS FOR USE LABELING FOR A COMPLETE LISTING OF INDICATIONS, WARNINGS AND PRECAUTIONS. LENSX® LASER IMPORTANT PRODUCT INFORMATION CAUTION: UNITED STATES FEDERAL LAW RESTRICTS THIS DEVICE TO SALE AND USE BY OR ON THE ORDER OF A PHYSICIAN OR LICENSED EYE CARE PRACTITIONER. INDICATION: THE LENSX® LASER IS INDICATED FOR USE IN PATIENTS UNDERGOING CATARACT SURGERY FOR REMOVAL OF THE CRYSTALLINE LENS. INTENDED USES IN CATARACT SURGERY INCLUDE ANTERIOR CAPSULOTOMY, PHACOFRAGMENTATION, AND THE CREATION OF SINGLE PLANE AND MULTI-PLANE ARC CUTS/INCISIONS IN THE CORNEA, EACH OF WHICH MAY BE PERFORMED EITHER INDIVIDUALLY OR CONSECUTIVELY DURING THE SAME PROCEDURE. RESTRICTIONS: PATIENTS MUST BE ABLE TO LIE FLAT AND MOTIONLESS IN A SUPINE POSITION. PATIENT MUST BE ABLE TO UNDERSTAND AND GIVE AN INFORMED CONSENT. PATIENTS MUST BE ABLE TO TOLERATE LOCAL OR TOPICAL ANESTHESIA. PATIENTS WITH ELEVATED IOP SHOULD USE TOPICAL STEROIDS ONLY UNDER CLOSE MEDICAL SUPERVISION. CONTRAINDICATIONS: CORNEAL DISEASE THAT PRECLUDES APPLANATION OF THE CORNEA OR TRANSMISSION OF LASER LIGHT AT 1030 NM WAVELENGTH. DESCEMETOCELE WITH IMPENDING CORNEAL RUPTURE. PRESENCE OF BLOOD OR OTHER MATERIAL IN THE ANTERIOR CHAMBER. POORLY DILATING PUPIL, SUCH THAT THE IRIS IS NOT PERIPHERAL TO THE INTENDED DIAMETER FOR THE CAPSULOTOMY. CONDITIONS WHICH WOULD CAUSE INADEQUATE CLEARANCE BETWEEN THE INTENDED CAPSULOTOMY DEPTH AND THE ENDOTHELIUM (APPLICABLE TO CAPSULOTOMY ONLY). PREVIOUS CORNEAL INCISIONS THAT MIGHT PROVIDE A POTENTIAL SPACE INTO WHICH THE GAS PRODUCED BY THE PROCEDURE CAN ESCAPE. CORNEAL THICKNESS REQUIREMENTS THAT ARE BEYOND THE RANGE OF THE SYSTEM. CORNEAL OPACITY THAT WOULD INTERFERE WITH THE LASER BEAM. HYPOTONY OR THE PRESENCE OF A CORNEAL IMPLANT. RESIDUAL, RECURRENT, ACTIVE OCULAR OR EYELID DISEASE, INCLUDING ANY CORNEAL ABNORMALITY (FOR EXAMPLE, RECURRENT CORNEAL EROSION, SEVERE BASEMENT MEMBRANE DISEASE). HISTORY OF LENS OR ZONULAR INSTABILITY. ANY CONTRAINDICATION TO CATARACT OR KERATOPLASTY. THIS DEVICE IS NOT INTENDED FOR USE IN PEDIATRIC SURGERY. WARNINGS: THE LENSX® LASER SYSTEM SHOULD ONLY BE OPERATED BY A PHYSICIAN TRAINED IN ITS USE. THE LENSX® LASER DELIVERY SYSTEM EMPLOYS ONE STERILE DISPOSABLE LENSX® LASER PATIENT INTERFACE CONSISTING OF AN APPLANATION LENS AND SUCTION RING. THE PATIENT INTERFACE IS INTENDED FOR SINGLE USE ONLY. THE DISPOSABLES USED IN CONJUNCTION WITH ALCON® INSTRUMENT PRODUCTS CONSTITUTE A COMPLETE SURGICAL SYSTEM. USE OF DISPOSABLES OTHER THAN THOSE MANUFACTURED BY ALCON MAY AFFECT SYSTEM PERFORMANCE AND CREATE POTENTIAL HAZARDS. THE PHYSICIAN SHOULD BASE PATIENT SELECTION CRITERIA ON PROFESSIONAL EXPERIENCE, PUBLISHED LITERATURE, AND EDUCATIONAL COURSES. ADULT PATIENTS SHOULD BE SCHEDULED TO UNDERGO CATARACT EXTRACTION. PRECAUTIONS: DO NOT USE CELL PHONES OR PAGERS OF ANY KIND IN THE SAME ROOM AS THE LENSX® LASER. DISCARD USED PATIENT INTERFACES AS MEDICAL WASTE. AES/COMPLICATIONS: CAPSULOTOMY, PHACOFRAGMENTATION, OR CUT OR INCISION DECENTRATION. INCOMPLETE OR INTERRUPTED CAPSULOTOMY, FRAGMENTATION, OR CORNEAL INCISION PROCEDURE. CAPSULAR TEAR. CORNEAL ABRASION OR DEFECT. PAIN. INFECTION. BLEEDING. DAMAGE TO INTRAOCULAR STRUCTURES. ANTERIOR CHAMBER FLUID LEAKAGE, ANTERIOR CHAMBER COLLAPSE. ELEVATED PRESSURE TO THE EYE. ATTENTION: REFER TO THE LENSX® LASER OPERATOR'S MANUAL FOR A COMPLETE LISTING OF INDICATIONS, WARNINGS AND PRECAUTIONS. © 2014 Novartis 11/14 LSX14078JAD continued on page 10 The Combined Ophthalmic Symposium will take place at the brand new JW Marriott hotel in Austin, Texas.

• Cover